Authors:
ECKHARDT SG
THURMAN A
KRAYNAK M
HIDALGO M
HANHAM A
VONHOFF DD
ROWINSKY EK
Citation: Sg. Eckhardt et al., A PHASE-I AND PHARMACOLOGICAL (PK) STUDY OF VESNARINONE, AN INDUCER OF DIFFERENTIATION AND APOPTOSIS, IN COMBINATION WITH GEMCITABINE, Annals of oncology, 9, 1998, pp. 478-478
Authors:
MATEI C
NEMUNAITIS J
GRIEGO C
HOFF P
HANHAM A
CALLAHAN J
PAZDUR R
Citation: C. Matei et al., PHASE-I TRIAL OF BOF-A2 (EMITEFUR) PLUS LEUCOVORIN (LV) IN PATIENTS WITH ADVANCED COLORECTAL-CANCER (CRC), Annals of oncology, 9, 1998, pp. 639-639
Authors:
CALABRESI PA
HANHAM A
CARLINO J
OLSEN J
MALONI H
MCFARLAND HF
RACKE MK
Citation: Pa. Calabresi et al., REPORT OF AN ONGOING PHASE-I TRIAL OF RECOMBINANT TRANSFORMING GROWTH-FACTOR-BETA-2 (TGF-BETA-2) IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS, Neurology, 45(4), 1995, pp. 417-418
Authors:
THOMPSON JT
GLASER BM
SJAARDA RN
MURPHY RP
HANHAM A
Citation: Jt. Thompson et al., EFFECTS OF INTRAOCULAR BUBBLE DURATION IN THE TREATMENT OF MACULAR HOLES BY VITRECTOMY AND TRANSFORMING GROWTH-FACTOR-BETA-2, Ophthalmology, 101(7), 1994, pp. 1195-1200
Authors:
THOMPSON JT
SMIDDY WE
GLASER BM
SJAARDA RN
FLYNN HW
HANHAM A
MURPHY RP
Citation: Jt. Thompson et al., INTRAOCULAR GAS TAMPONADE DURATION AND SUCCESS OF MACULAR HOLE TREATMENT BY VITRECTOMY AND TGF-BETA-2, Investigative ophthalmology & visual science, 35(4), 1994, pp. 1712-1712
Authors:
SMIDDY WE
GLASER BM
THOMPSON JT
SJAARDA RN
FLYNN HW
HANHAM A
MURPHY RP
Citation: We. Smiddy et al., TRANSFORMING GROWTH-FACTOR-BETA-2 SIGNIFICANTLY ENHANCES THE ABILITY TO FLATTEN THE RIM OF SUBRETINAL FLUID SURROUNDING MACULAR HOLES - PRELIMINARY ANATOMIC RESULTS OF A MULTICENTER PROSPECTIVE RANDOMIZED STUDY, Retina, 13(4), 1993, pp. 296-301
Authors:
LANSING MB
GLASER BM
LISS H
HANHAM A
THOMPSON JT
SJAARDA RN
GORDON AJ
Citation: Mb. Lansing et al., THE EFFECT OF PARS-PLANA VITRECTOMY AND TRANSFORMING GROWTH-FACTOR-BETA-2 WITHOUT EPIRETINAL MEMBRANE PEELING ON FULL-THICKNESS MACULAR HOLES, Ophthalmology, 100(6), 1993, pp. 868-871